Published in Drug Week, January 21st, 2011
"It is treated in the terminal phase via dialysis and transplantation. Posttransplantation recurrence is common, but evolves slowly," wrote P. Hidalgo and colleagues.
The researchers concluded: "Herein, recovery of native kidney function 10 years after transplantation in a patient with IgA glomerulonephritis is described, and the potential effect of immunosuppression therapy, in particular with mycophenolate mofetil, is discussed."
Hidalgo and colleagues published their study...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2011-01-21)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.